For The Better

It’s a smart move to buy Micron’s shares after their recent pullback.

A new NASA contract could be worth $10 billion — or $15 billion — to Voyager Technologies (and others).

Management outlines interim analysis timing and new survival data plans.

Fiber coverage hits 50% of its footprint as hyperscaler demand accelerates.

Reimbursed treatments are steadily displacing discounted programs.

The rule boils down to two tests. Would the stock still pass them at today’s price?

AI-related stocks rallied, and Elon Musk’s Terafab has high ambitions.

A delayed multiyear deal and memory market pressure tested an otherwise strong quarter.

Quality equity outflows weighed, but fixed income and ETFs kept momentum.

CoreWeave and Nebius have sold off hard, and this week’s earnings could show how much the midterm results and higher borrowing costs are weighing on their growth plans.

A $1 million nest egg may seem generous, but on an annual basis, it could leave you short of your goals.

Major indexes fell hard last week, but history has promising news for investors.

Walmart trades at more than 45 times earnings, while Target trades at 17. Here’s why the valuation gap isn’t as simple as it looks.

Management outlined AXPAXLI’s regulatory path and late-stage trial updates.

Management ties a $32M software phaseout to a margin push in 2027.

Contract wins and a 25,000-bed pipeline fueled a strong quarter, but watch the leverage.

Nuclear fleet posted a 99.2% summer capacity factor and expanded long-term contracts.

SMR stocks are getting hammered alongside AI stocks.

It wasn’t only Halloween that had investors scared in October.

Nvidia’s board of directors is launching an investigation into whether CEO Jensen Huang was the target of a “foreign intelligence effort.”